News Summary

Latent Labs, a startup emerging from stealth with $50 million in funding, has launched a web-based AI model named LatentX. This tool is designed to democratize protein design, enabling academic institutions, biotech startups, and pharmaceutical companies to design novel proteins directly through their browsers using natural language. The model has achieved state-of-the-art results in lab testing, distinguishing itself from competitors like AlphaFold by not only predicting existing structures but also generating entirely new proteins. LatentX aims to facilitate faster therapeutic development by creating novel molecular designs, such as nanobodies and antibodies. The company’s business model involves licensing this model for external use, offering it for free initially, with plans to introduce charges for advanced features in the future. Latent Labs is supported by notable investors, including Radical Ventures and Sofinnova Partners.